Evidence map›Paper›PMID 31727827›Full record

ReviewScience (New York, N.Y.)2019

Cellular RNA surveillance in health and disease.

Sandra L Wolin, Lynne E Maquat

Open access · greenAbstract readReview
In one paragraph

Review in Science (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 158 citations in OpenAlex.

  1. YBX1 regulates RNA polymerase III transcripts to prevent inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. TRAMP assembly alters the conformation and RNA binding of Mtr4 and Trf4-Air2.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sandra L WolinRNA Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA. sandra.wolin@nih.gov lynne_maquat@urmc.rochester.edu.ORCID 0000-0001-6730-0399
Lynne E MaquatDepartment of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA. sandra.wolin@nih.gov lynne_maquat@urmc.rochester.edu.ORCID 0000-0001-7192-732X
National Cancer Institute · USUniversity of Rochester · US

Funding

Biogenesis, Function and Turnover of Noncoding RNAsZIABC011757 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOLIN, SANDRA · 2017 to 2025
$20.4M
REGULATION OF SELENOPROTEIN RNA METABOLISMR01GM059614 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 1999 to 2022
$9.1M
Regulation of Normal and Defective Human GenesR37GM074593 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 2014 to 2023
$4.8M
Regulation of Normal and Defective Human GenesR01GM074593 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 2006 to 2013
$3.1M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC011757NIGMS NIH HHS R01 GM059614NIGMS NIH HHS R01 GM074593NIGMS NIH HHS R37 GM074593
6 · The paper itself

Abstract

The numerous quality control pathways that target defective ribonucleic acids (RNAs) for degradation play key roles in shaping mammalian transcriptomes and preventing disease. These pathways monitor most steps in the biogenesis of both noncoding RNAs (ncRNAs) and protein-coding messenger RNAs (mRNAs), degrading ncRNAs that fail to form functional complexes with one or more proteins and eliminating mRNAs that encode abnormal, potentially toxic proteins. Mutations in components of diverse RNA surveillance pathways manifest as disease. Some mutations are characterized by increased interferon production, suggesting that a major role of these pathways is to prevent aberrant cellular RNAs from being recognized as "non-self." Other mutations are common in cancer, or result in developmental defects, revealing the importance of RNA surveillance to cell and organismal function.

Indexed as

RNA StabilityAnimalsDiseaseHumansMutationRNA, MessengerRNA, UntranslatedTranscriptomeRNA, MessengerRNA, Untranslated

Identifiers

PMID31727827
PMCPMC6938259
OpenAlexW2985200437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.